Opioids are known for their powerful pharmacokinetics for pain relief, but are now well recognized for their overuse and abuse through prescriptions provided by healthcare providers. This has created a medical oxymoron: well-meaning pain management as a valued, caring practice for successful recovery from both medical problems and surgical procedures, juxtaposed by the alarming growth of opioids' prescriptive footprint.
Recent data has revealed the live attenuated influenza vaccine (LAIV), also known as the “nasal spray” vaccine, to be grossly ineffective, leading to the ACIP’s decision not to recommend its usage. As such, healthcare providers must be judicious in their choice of influenza vaccine with their patients.
Egg allergies are no longer a contraindication for influenza vaccination, but intranasal mists won’t be an alternative for the shot during this year’s flu season, either, according to new recommendations released by the American Academy of Pediatrics.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a study published in Pediatrics. The study examined footage of parents putting their child down to sleep to discover if they are following safe sleep messages.
Opioid abuse rates have reached epidemic proportions, doubling since the 1990s, and—despite the documented success of medication-assisted therapies in treating opioid addiction—less than half of teens with opioid abuse disorders receive such treatment.
In the throes of an opioid epidemic, the US Food and Drug Administration (FDA) decided in August 2015 to expand the indications for OxyContin, an extended-release form of the narcotic oxycodone, to children aged 11 years and older. The decision sparked outrage in those who fear the move might fuel increasing opioid addiction among young Americans.